Papillary serous cystadenocarcinoma
| Papillary serous cystadenocarcinoma | |
|---|---|
.jpg) | |
| Medium power slide of ovarian serous adenocarcinoma stained using haematoxylin and eosin | |
| Specialty | Oncology  |
Papillary serous cystadenocarcinomas are the most common form of malignant ovarian cancer making up 26 percent of ovarian tumours in women aged over 20 in the United States.[1]
As with most ovarian tumours, due to the lack of early signs of disease these tumours can be large when discovered and have often metastasized, often by spreading along the peritoneum.[2]
Histopathology
[edit]Papillary serous cystadenocarcinomas may exhibit psammoma bodies upon histopathology.[3]
Diagnosis
[edit]![[icon]](/wiki/File:Wiki_letter_w_cropped.svg){kind=small} | This section is empty. You can help by adding to it. (June 2018) |
Epidemiology
[edit]
Gallery
[edit]-
Papillary serous cystadenoma
References
[edit]- ^ a b Kosary CL (2007). "Chapter 16: Cancers of the Ovary". In Ries LA, Young JL, Keel GE, Eisner MP, Lin YD, Horner MJ (eds.). SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988-2001, Patient and Tumor Characteristics. SEER Program. Vol. NIH Pub. No. 07-6215. Bethesda, MD: National Cancer Institute. pp. 133–144. Archived from the original on 2013-10-10.
- ^ "The Internet Pathology Laboratory for Medical Education". The University of Utah Eccles Health Sciences Library. Retrieved 2009-06-27.
- ^ Ovarian papillary serous cystadenocarcinoma at WebPath, The Internet Pathology Laboratory for Medical Education at Mercer University School of Medicine. Retrieved July 2011